# Valganciclovir

NDC: 71921-210
Generic name: Valganciclovir
Labeler / Manufacturer: Florida Pharmaceutical Products, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20230701

FDA application: ANDA216317

## Active ingredients

- VALGANCICLOVIR: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71921-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71921-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc6c4939-7908-439c-b1b8-6b52e826c7a5